A €3 million invoice for a single infusion can dazzle as easily as it alarms. Gene therapies such ...
Read moreThe vast majority of products launching in the UK will be assessed by the National Institute for Hea...
Read moreDecisions regarding National Institute for Health and Care Excellence (NICE) appraisals are not made...
Read moreThe National Institute of Health and Care Excellence (NICE) has published several updates and releas...
Read moreMost pharmaceutical products hoping to launch in the UK will be assessed by NICE as a Single Technol...
Read moreSecuring a positive recommendation from the National Institute for Health and Care Excellence (NICE)...
Read moreWhen bringing a new health technology to market in England, pharmaceutical and biotech companies mus...
Read moreExecutive Summary What Has Changed in the Pharma Package? The Council’s agreed text on the Pha...
Read moreThe increasing complexity of bringing innovative therapies to market across various jurisdictions pr...
Read moreIn the current pharmaceutical environment, obtaining regulatory approval is no longer enough to ensu...
Read more